Cellectis S.A. (EPA: ALCLS)
France flag France · Delayed Price · Currency is EUR
2.100
+0.030 (1.45%)
Aug 30, 2024, 5:35 PM CET

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 210.20 million. The enterprise value is 154.81 million.

Market Cap 210.20M
Enterprise Value 154.81M

Important Dates

The next estimated earnings date is Friday, September 6, 2024.

Earnings Date Sep 6, 2024
Ex-Dividend Date n/a

Share Statistics

Cellectis has 100.09 million shares outstanding.

Shares Outstanding 100.09M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.52%
Owned by Institutions (%) 15.36%
Float 71.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.10
PB Ratio 1.52
P/FCF Ratio 4.54
PEG Ratio n/a

Enterprise Valuation

EV / Earnings -2.10
EV / Sales 8.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 3.34

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 60.36.

Current Ratio 1.92
Quick Ratio 1.10
Debt / Equity 60.36
Debt / EBITDA n/a
Debt / FCF 1.81
Interest Coverage -13.16

Financial Efficiency

Return on equity (ROE) is -64.37% and return on invested capital (ROIC) is -26.00%.

Return on Equity (ROE) -64.37%
Return on Assets (ROA) -17.30%
Return on Capital (ROIC) -26.00%
Revenue Per Employee 83,677
Profits Per Employee -336,265
Employee Count 219
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.81% in the last 52 weeks. The beta is 3.22, so Cellectis's price volatility has been higher than the market average.

Beta (5Y) 3.22
52-Week Price Change +8.81%
50-Day Moving Average 1.86
200-Day Moving Average 2.36
Relative Strength Index (RSI) 64.22
Average Volume (20 Days) 42,626

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 18.33 million and -73.64 million in losses. Loss per share was -1.04.

Revenue 18.33M
Gross Profit 17.64M
Operating Income -82.00M
Pretax Income -73.96M
Net Income -73.64M
EBITDA -72.23M
EBIT -82.00M
Loss Per Share -1.04

Balance Sheet

The company has 139.10 million in cash and 83.72 million in debt, giving a net cash position of 55.38 million or 0.55 per share.

Cash & Cash Equivalents 139.10M
Total Debt 83.72M
Net Cash 55.38M
Net Cash Per Share 0.55
Equity (Book Value) 138.70M
Book Value Per Share 1.39
Working Capital 136.42M

Cash Flow

In the last 12 months, operating cash flow was 48.05 million and capital expenditures -1.72 million, giving a free cash flow of 46.33 million.

Operating Cash Flow 48.05M
Capital Expenditures -1.72M
Free Cash Flow 46.33M
FCF Per Share 0.46

Margins

Gross Margin 96.25%
Operating Margin -447.44%
Pretax Margin -403.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin 252.82%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -49.61%
FCF Yield 22.04%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a